Andy Chevigné and his team, RTI-5152-twelve is postulated to improve the amounts of opioid peptides that bind to classical opioid receptors within the brain, leading to heightened painkilling activity. The LIH-RTI research groups set up a collaboration agreement and submitted a joint pate